Patents by Inventor Michael Hannus

Michael Hannus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High complexity siRNA pools
    Patent number: 10407677
    Abstract: The present invention relates to a method for producing pools of siRNA molecules suitable for RNA interference.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: September 10, 2019
    Assignees: INTANA BIOSCIENCE GmbH, siTools Biotech GmbH
    Inventors: Gunter Meister, Michael Hannus
  • HIGH COMPLEXITY siRNA POOLS
    Publication number: 20150132848
    Abstract: The present invention relates to a method for producing pools of siRNA molecules suitable for RNA interference.
    Type: Application
    Filed: April 25, 2013
    Publication date: May 14, 2015
    Inventors: Gunter Meister, Michael Hannus
  • Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
    Patent number: 8507546
    Abstract: The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular malaria.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: August 13, 2013
    Assignees: Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Cenix Bioscience GmbH
    Inventors: Michael Hannus, Cecilie Martin, Maria M. Mota, Miguel Prudencio, Christina Dias Rodrigues
  • USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES
    Publication number: 20120276121
    Abstract: The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular malaria.
    Type: Application
    Filed: July 13, 2012
    Publication date: November 1, 2012
    Applicants: INSTITUTO DE MEDICINA MOLECULAR, FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA, CENIX BIOSCIENCE GMBH
    Inventors: MICHAEL HANNUS, CECILIE MARTIN, MARIA M. MOTA, MIGUEL PRUDENCIO, CHRISTINA DIAS RODRIGUES
  • Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases
    Publication number: 20090324580
    Abstract: The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular malaria.
    Type: Application
    Filed: March 9, 2007
    Publication date: December 31, 2009
    Applicants: CENIX BIOSCIENCE GMBH, INSTITUTO DE MEDICINA MOLECULAR , FACULDADE DE MEDICINA DA UNIVERSIDADA DE LISBOA
    Inventors: Michael Hannus, Cecilie Martin, Maria M. Mota, Miguel Prudencio, Christina Dias Rodrigues
  • Human Marker Genes and Agents for Diagnosis, Treatment and Prophylaxis of Cardiovascular Disorders and Artherosclerosis
    Publication number: 20090214477
    Abstract: The invention relates to novel targets in the screening for compounds useful in the treatment and/or prophylaxis of a disease selected from the group comprising cardiovascular diseases, disorders of lipid metabolism or atherosclerosis. The invention relates to novel compounds for use as a medicament for diseases or conditions involving a disease selected from the group comprising cardiovascular diseases, disorders of lipid metabolism or atherosclerosis. The invention especially relates to antagonists and expression-inhibitory compounds that target G-protein coupled receptors (GPCRs), kinases and proteases, and to methods for identifying such compounds. The invention further relates to methods for identifying these antagonists and expression-inhibitory compounds, and methods for diagnosing a disease selected from the group comprising cardiovascular diseases, disorders of lipid metabolism or atherosclerosis or a susceptibility to such a condition.
    Type: Application
    Filed: April 8, 2006
    Publication date: August 27, 2009
    Applicant: Cenix BioScience GmbH
    Inventors: Ulrich Betz, Donatella D'Urso, Peter Kolkhof, Michael Seewald, Jochen Strayle, Anne Plötner, Michael Hannus